Abstract
10571 Background: Childhood cancer survivors (CCS) are exposed to nephrotoxic treatments. We assessed renal function (RF), and factors associated with chronic kidney disease (CKD) in a large cohort of long-term CCS unexposed to abdominal irradiation. Methods: We evaluated 2,314 SJLIFE participants ( > 10 years (yrs) post-diagnosis, age ≥ 18 yrs) measuring serum sodium, potassium, magnesium, urinalysis (hematuria ≥ 5 RBC/hpf; proteinuria ≥ 1+ protein), and estimated glomerular filtration rate (eGFR) using the CKD Epidemiology Collaboration (CKD-EPI) equation. CKD was defined according to the National Kidney Foundation Kidney Disease Outcome Quality Initiative. Logistic regression, adjusting for length of follow-up, was used to estimate odds ratios (ORs) and 95% confidence intervals (CI) for the association between demographic and clinical factors, and CKD. Results: 1110(48%) survivors were female. 1920(83%) were non-Hispanic white. Median age at diagnosis-6.9 yrs (interquartile range [IQR] = 3.2-12.6), median age at RF evaluation-31 yrs (IQR = 25.3-37.0), and median elapsed time from diagnosis to evaluation-23 yrs (IQR = 17.3-29.4). 70(3.0%) were hypokalemic ( < 3.4 mmol/L or taking supplement), 39(1.7%) hypomagnesemic ( < 1.3 meq/dL or taking supplement) and 12(0.5%) hyponatremic ( < 134 mmol/L or taking supplement). Survivors with No CKD or CKD Grades 1-5 were 93.6%, 4.1%, 0.9%, 1.2%, 0.1%, and 0.1%, respectively. In multivariable analyses, non-Hispanic black race (OR = 2.19, 1.43-3.34), history of nephrectomy (OR = 2.74, (1.39- 5.41)), increased body mass index (BMI) (BMI 35-40 vs ≤ 25, OR = 2.36 (1.38-4.05), BMI ≥ 40 vs > 0-25 (OR = 2.15 (1.21-3.82)), history of treatment with ifosfamide (IFOS) (OR = 2.24 (1.23-4.06)), or cis-platinum (DDP) (OR = 1.89 (1.10-3.23)) were associated with CKD Grade 1-5 vs No CKD. age at RF evaluation ≥ 50 yrs vs ≥ 18-30 yrs (OR = 6.72 (1.06-42.79)), history of treatment with IFOS (OR = 7.23 (2.47-21.12)), or DDP (OR = 5.25 (2.14-12.85)) exposure were risk factors for CKD = Grade 3-5 vs No CKD. High-dose cyclophosphamide ( ≥ 1000 mg/m2/course) was not associated with CKD. Conclusions: CKD and abnormalities of electrolyte concentrations are infrequent among CCS. BMI, race/ethnicity, and treatment may be associated with CKD.